Sui Li Cheng - Net Worth and Insider Trading
Sui Li Cheng Net Worth
The estimated net worth of Sui Li Cheng is at least $452,200 dollars as of 2025-05-01. Sui Li Cheng is the Executives of Jinling Pharmaceutical Co Ltd and owns about 70,000 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) stock worth over $452,200. Details can be seen in Sui Li Cheng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sui Li Cheng has not made any transactions after 2018-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Sui Li Cheng
Sui Li Cheng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sui Li Cheng owns 1 companies in total, including Jinling Pharmaceutical Co Ltd (SZSE:000919) .
Click here to see the complete history of Sui Li Cheng’s form 4 insider trades.
Insider Ownership Summary of Sui Li Cheng
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SZSE:000919 | Jinling Pharmaceutical Co Ltd | 2018-02-06 | Executives |
Sui Li Cheng Latest Holdings Summary
Sui Li Cheng currently owns a total of 1 stock. Sui Li Cheng owns 70,000 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) as of February 6, 2018, with a value of $452,200.
Latest Holdings of Sui Li Cheng
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SZSE:000919 | Jinling Pharmaceutical Co Ltd | 2018-02-06 | 70,000 | 6.46 | 452,200 |
Holding Weightings of Sui Li Cheng
Sui Li Cheng Form 4 Trading Tracker
According to the SEC Form 4 filings, Sui Li Cheng has made a total of 0 transactions in Jinling Pharmaceutical Co Ltd (SZSE:000919) over the past 5 years. The most-recent trade in Jinling Pharmaceutical Co Ltd is the acquisition of 9,300 shares on February 6, 2018, which cost Sui Li Cheng around $74,400.
Insider Trading History of Sui Li Cheng
- 1
Sui Li Cheng Trading Performance
GuruFocus tracks the stock performance after each of Sui Li Cheng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sui Li Cheng is -2.08%. GuruFocus also compares Sui Li Cheng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sui Li Cheng within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sui Li Cheng's insider trading performs compared to the benchmark.
Performance of Sui Li Cheng
Sui Li Cheng Ownership Network
Ownership Network List of Sui Li Cheng
Ownership Network Relation of Sui Li Cheng

Sui Li Cheng Owned Company Details
What does Jinling Pharmaceutical Co Ltd do?
Who are the key executives at Jinling Pharmaceutical Co Ltd?
Sui Li Cheng is the Executives of Jinling Pharmaceutical Co Ltd. Other key executives at Jinling Pharmaceutical Co Ltd include Executives Jia Ming Yi , Executives Li Quan , and Executives Chen Sheng .
Jinling Pharmaceutical Co Ltd (SZSE:000919) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jinling Pharmaceutical Co Ltd (SZSE:000919)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jinling Pharmaceutical Co Ltd Insider Transactions
Sui Li Cheng Mailing Address
Above is the net worth, insider trading, and ownership report for Sui Li Cheng. Currently GuruFocus does not have mailing address information for Sui Li Cheng.